Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
This review examines GLP-1 receptor agonists within the orthopedic context, exploring how their metabolic and anti-inflammatory effects may influence patient care, surgical outcomes, and postoperative recovery
Nat Rev Endocrinol 2009;5:285288
Globally, the GLP-1 receptor agonist market is valued at USD 62.86 billion in 2025, projected to surge at a 17.5% compound annual growth rate (CAGR) through 2034, driven by expanding indications for obesity, cardiovascular benefits, and even potential neuroprotective effects
z.o.o., 2024
IELs can be classified into two principal subpopulations: natural IELs and induced IELs
US$ 28.80
US$ 25.33
US$ 29.86
